How Do Clinical And Histological Differences Between Hypertrophic Scars And Keloids Influence Laser Selection And Treatment Response In Medical Aesthetic Clinics?

Clinical classification should come before laser selection. Hypertrophic scars remain within the original wound and often regress, while keloids extend into surrounding skin and rarely resolve spontaneously. Because hypertrophic scars are generally more vascular and structurally organized, they often respond more predictably to vascular and remodeling lasers; mature keloids, with dense disorganized collagen and lower vascularity, usually require combination treatment and carry a higher recurrence risk.

The wound boundary is the most useful initial distinction: a confined, potentially regressing scar is more likely to respond to laser therapy alone, whereas an expanding scar beyond the original injury should be treated as a keloid-prone lesion requiring cautious parameters, adjunctive therapy, and recurrence planning.

Why the Diagnosis Changes the Treatment Plan

Hypertrophic scars remain within the injury

Hypertrophic scars typically develop within several weeks of wound closure or trauma. They are raised, firm, and often red or pink, but remain confined to the original wound dimensions.

Their tendency toward gradual spontaneous regression makes them more suitable for staged laser treatment, particularly when redness, stiffness, and textural irregularity are the main concerns.

Keloids extend beyond the original wound

Keloids grow beyond the initial wound margins into previously unaffected skin. They may appear weeks to years after injury, continue enlarging, and are more common in people with darker skin phototypes.

They may be firm, shiny, tender, itchy, or bosselated. Telangiectasia can occur, but visible surface vessels do not necessarily indicate that the deeper lesion is predominantly vascular.

The boundary is more reliable than appearance alone

Both lesions can be raised, erythematous, and firm. A history of wound expansion beyond the original injury is therefore more diagnostically useful than color or elevation alone.

When the diagnosis is uncertain, rapidly changing, atypical, ulcerated, or unusually pigmented, clinical reassessment and, where appropriate, histopathological evaluation should precede elective laser treatment.

How Histology Influences Laser Response

Hypertrophic scars have more organized collagen

Hypertrophic scars generally contain relatively organized collagen bundles and a comparatively scant mucoid matrix. Their vascular component is often clinically relevant, especially during the early erythematous phase.

This combination gives clinicians two treatment targets: vascular activity for redness and inflammation, and collagen remodeling for thickness, pliability, and texture.

Keloids contain dense, disorganized collagen

Keloids contain thick, haphazardly arranged, often hyalinized collagen within a prominent mucoid matrix. Their fibroproliferative behavior is more persistent than that of hypertrophic scars.

The dense architecture can limit the effectiveness of treatments that act primarily on superficial vessels. A reduction in vascularity may improve redness without adequately controlling the underlying abnormal collagen response.

Tissue maturity matters

A vascular, relatively early scar and a dense, mature plaque should not be treated as equivalent lesions. The same diagnosis can require different laser priorities depending on redness, thickness, pliability, symptoms, and duration.

Selecting Lasers for Hypertrophic Scars

Pulsed dye laser for vascular, erythematous scars

Pulsed dye lasers are most useful when vascularity and erythema are prominent. Their vascular-selective action can reduce redness and may also contribute to improvement in scar activity and pliability.

Early hypertrophic scars and selected small, vascular keloids may respond better than mature, dense keloid plaques. Treatment should still be conservative and staged, because scar biology and skin phototype influence both efficacy and adverse-event risk.

Fractional lasers for texture and pliability

Fractional ablative or non-ablative systems, including fractional CO₂ or Er:YAG approaches, can create controlled microthermal injury that encourages remodeling of abnormal collagen.

They are generally more relevant when the primary problems are thickness, surface irregularity, stiffness, or restricted pliability rather than redness alone. In hypertrophic scars, this approach may be used after or alongside vascular treatment.

Expected response is often more predictable

The primary reference reports approximately 50–80% improvement in many hypertrophic scars after several laser sessions, although results vary by scar age, location, thickness, treatment parameters, and outcome measure.

This figure should be used as a clinical expectation rather than a guarantee. Improvement may involve redness, texture, size, and pliability, and these domains do not always improve at the same rate.

Selecting Lasers for Keloids

Vascular lasers may address only part of the lesion

A pulsed dye laser can be considered when a keloid is visibly vascular or erythematous, particularly when the lesion is small or relatively early. However, mature keloids commonly have a less vascular, collagen-dominant base.

Consequently, vascular treatment alone may reduce surface redness without preventing continued growth or recurrence. A limited response should not automatically be interpreted as incorrect technique; it may reflect the lesion’s underlying architecture.

Fractional treatment targets remodeling

Fractional ablative or non-ablative lasers may be used to address dense texture and improve remodeling. In practice, they are usually considered as part of a broader plan rather than as definitive monotherapy for an active keloid.

Aggressive tissue injury can be counterproductive in keloid-prone patients. Treatment intensity, density, and interval should therefore reflect the risk of provoking further scar proliferation.

Nd:YAG may be useful in selected protocols

Long-pulsed Nd:YAG systems can be considered when a deeper or vascular-remodeling effect is desired, depending on lesion characteristics and the clinician’s established protocol.

The choice should not be made solely by wavelength. Pulse duration, fluence, cooling, treatment density, skin phototype, and lesion depth all affect safety and response.

Adjuvant therapy is often essential

Keloid management commonly requires intralesional corticosteroids or other clinician-directed adjuvant approaches, sometimes combined with surgery. Excision alone is particularly vulnerable to recurrence and should not be viewed as a definitive solution without a recurrence-prevention strategy.

Silicone sheeting, pressure therapy, and other supportive measures may also be incorporated where clinically appropriate. The key principle is to control the abnormal wound-healing response rather than simply resurface the lesion.

Understanding the Trade-offs

Laser alone is not equally appropriate for both scars

Hypertrophic scars often provide a more favorable risk–benefit profile for laser treatment because they may regress and remain localized. Keloids are biologically more persistent, so laser monotherapy may produce incomplete improvement or recurrence.

A combined plan may be more rational than escalating laser energy when the lesion is not responding.

More aggressive treatment is not automatically better

Increasing fluence, depth, or treatment density can increase inflammation, post-inflammatory hyperpigmentation, prolonged erythema, and—in susceptible patients—further scar formation.

This concern is especially important for darker skin phototypes and for keloids located on high-tension areas such as the presternal chest, shoulders, and upper back.

Color improvement does not equal disease control

A scar may become less red while remaining thick, firm, or biologically active. Clinics should separately assess erythema, elevation, pliability, symptoms, surface texture, and expansion beyond the wound.

This prevents a vascular response from being mistaken for complete keloid control.

Treatment intervals should allow reassessment

Scars remodel slowly, and immediate post-treatment changes can obscure the eventual result. Staged sessions with documented photography, palpation, and symptom review are safer than rapid escalation based only on early appearance.

A recurrence or continued expansion should prompt diagnostic and treatment-plan reassessment.

How Clinics Can Apply the Distinction

Establish a baseline before treatment

Document the original wound boundaries, current scar dimensions, color, thickness, firmness, pliability, symptoms, and duration. Marking or photographing the original injury area can help identify whether the lesion has crossed its borders.

Also record skin phototype, previous treatments, history of keloids, and areas of mechanical tension.

Match the primary target to the modality

If redness and vascularity dominate, a vascular laser may be appropriate. If thickness, stiffness, or texture dominates, fractional remodeling may be more relevant.

For an expanding, dense, or recurrent keloid, laser selection should be integrated with medical or surgical adjuncts rather than treated as an isolated cosmetic procedure.

Use conservative protocols for high-risk patients

Perform appropriate test treatment when indicated, use careful cooling and phototype-adjusted parameters, and monitor for prolonged inflammation or pigmentary change.

Patients should understand that the goal may be improvement in symptoms, color, and pliability—not guaranteed eradication.

Making the Right Choice for Your Goal

The most reliable approach is to classify the scar first, then select the laser according to its dominant biological and clinical features.

If your primary focus is reducing redness in an early hypertrophic scar: Consider a vascular-targeted approach such as pulsed dye laser, with staged reassessment for changes in erythema and pliability.
If your primary focus is improving thickness or texture in a hypertrophic scar: Consider fractional remodeling treatment, provided the scar is stable and the parameters are appropriate for the patient’s skin phototype.
If your primary focus is treating a mature or expanding keloid: Avoid relying on vascular laser treatment alone; develop a combination plan that may include fractional or other selected laser therapy plus clinician-directed intralesional or surgical adjuncts.
If your primary focus is minimizing recurrence: Treat keloid-prone tissue conservatively, address mechanical tension, and include a documented follow-up and recurrence-prevention strategy.

Accurate scar classification turns laser treatment from a generic resurfacing procedure into a biologically informed treatment plan.

Summary Table:

Feature	Hypertrophic Scar	Keloid
Extent	Confined to original wound	Extends beyond original wound
Spontaneous regression	Common	Rare
Collagen organization	Organized, parallel	Disorganized, haphazard
Vascularity	Higher, especially early	Variable, often lower in mature lesions
Laser response	More predictable	Less predictable, requires combination therapy
Recurrence risk	Lower	Higher

Optimize your scar treatment outcomes with BELIS. Our advanced laser systems, including Pulsed Dye, Fractional CO2, and Nd:YAG, are designed to address the distinct challenges of hypertrophic scars and keloids. For clinics and premium salons seeking professional-grade equipment, we offer comprehensive solutions backed by OEM/ODM support and certifications. Contact us today to elevate your practice and deliver superior patient care.

Get in touch